| --- |
| title: "House Oversight: Estate Documents (Nov 12) (HOUSE_OVERSIGHT_024804)" |
| source: "House Oversight: Estate Documents (Nov 12)" |
| sourceUrl: "https://www.justice.gov/epstein" |
| date: "2026-01-01" |
| category: "House Oversight" |
| eftaNumber: "HOUSE_OVERSIGHT_024804" |
| ocrPages: 1 |
| ocrChars: 2558 |
| ocrElapsed: 0.0 |
| parseTier: "external-legacy" |
| engine: "engine undisclosed (ep-nov-12.greg.technology mirror)" |
| externalSource: "greg-ep-nov-12" |
| externalLicense: "not granted" |
| externalCredit: "ep-nov-12.greg.technology" |
| externalUrl: "https://ep-nov-12.greg.technology" |
| --- |
| |
| ACKRELL |
| CAPITAL |
| Cannabis Investment Report | December 2017 |
| Other Risks to Companies in the Cannabis Industry |
| • The cannabis industry is extremely competitive in most segments, with certain companies hav- |
| ing unique competitive advantages such as greater capital resources, first-mover advantage, more |
| scalable business models and greater brand recognition. |
| • To date, the research conducted on cannabinoid-derived pharmaceuticals and other cannabis- |
| based therapies is limited. There is no assurance that cannabinoid-derived pharmaceuticals or |
| other medical products will prove effective in treating medical conditions or achieve broad mar- |
| ket acceptance. |
| • Given the emerging nature of the cannabis industry, there is a scarcity of qualified personnel with |
| deep industry experience and significant competition for such qualified personnel. Many canna- |
| bis companies may not be successful in attracting, training, integrating, motivating or retaining |
| qualified management teams and other personnel. |
| • Cannabis is an agricultural product. The occurrence of diseases, insects, pests, mold and other |
| infestations and severe adverse environmental conditions, such as fire, drought, hail, flood or |
| frost, is unpredictable, may have a potentially devastating impact on agricultural production of |
| cannabis and may otherwise adversely affect the supply of cannabis. |
| • The cannabis industry is particularly vulnerable to rapidly changing technology, government |
| regulation and relatively high risks of obsolescence caused by scientific and technological |
| advances. The success of cannabis companies will depend in part on their ability to anticipate |
| market, legal, technological and other trends in the industry. Many cannabis companies will fail |
| to accurately identify or predict industry trends. |
| • Cannabis laws and regulations in jurisdictions outside the United States vary widely and, in |
| some cases, are as complex, contradictory and rapidly changing as those within the United States. |
| Cannabis companies operating outside the country's borders are subject to risks related to the |
| unsettled legal environment applicable to cannabis. |
| • Due to federal controls on cannabis within the United States and similar restrictions in many |
| jurisdictions outside the country, there is a significant black market for cannabis products. |
| Government-regulated cannabis businesses face competition from black market participants and |
| are subject to different market forces than those of the black market. |
| 168 |
| © 2017 Ackrell Capital, LLC | Member FINRA / SIPC |
| HOUSE_OVERSIGHT_024804 |
|
|
